Table 2.
The demographic data, clinical features, treatment, and outcome of malignant eyelid tumors.
| Malignant eyelid tumors (n = 227) | Number (%) | Gender (M/F) | Mean age | (years, range) | Laterality∗ (R/L/B) | Location∗ (U/L/B) | Adjunct treatment | Recurrence | Mortality | |
|---|---|---|---|---|---|---|---|---|---|---|
| Chemo/radiation/CCRT | Exenteration/enucleation | Number (%) | Number (%) | |||||||
| Basal cell carcinoma | 131 (57.8%) | 90/41 | 72.5 | (21–93) | 55/64/3 | 25/90/0 | 0/0/0 | 1/0 | 8 (6.1%) | 0 (0%) |
| Sebaceous gland carcinoma | 48 (21.1%) | 20/28 | 74.1 | (44–91) | 23/25/0 | 27/19/1 | 0/3/0 | 5/0 | 10 (20.8%) | 1 (2.1%) |
| Squamous cell carcinoma | 23 (10.1%) | 16/7 | 71.7 | (40–93) | 8/15/0 | 7/6/0 | 0/0/4 | 2/2 | 7 (30.4%) | 3 (13.0%) |
| Melanoma | 8 (3.5%) | 6/2 | 67.4 | (21–84) | 2/6/0 | 3/2/0 | 1/0/0 | 5/0 | 0 (0%) | 2 (25.0%) |
| Adenocarcinoma | 5 (2.2%) | 4/1 | 73.8 | (64–88) | 1/4/0 | 0/1/0 | 0/1/1 | 3/0 | 0 (0%) | 1 (20%) |
| Adenoid cystic carcinoma | 2 (0.9%) | 0/2 | 53.0 | (47–59) | 1/1/0 | 1/0/0 | 0/2/0 | 2/0 | 1 (50%) | 0 (0%) |
| Others∗∗ | 10 (4.4%) | 8/2 | 71.7 | (46–90) | 5/4/0 | 5/1/0 | 1/1/1 | 2/0 | 1 (10%) | 1 (10%) |
∗Total number not equal to 100% of cases because of incomplete chart information or data missing.
∗∗Others including small cell carcinoma, epidermoid carcinoma, merkel cell carcinoma, B-cell lymphoma, T-cell lymphoma, lymphoepithelial carcinoma, invasive nonkeratinizing carcinoma, myeloid sarcoma, angiosarcoma, and malignant proliferating pilar tumor.